Zacks.com on MSN1h
Biotech Stock Roundup: NVAX Q3 Results, SNDX Down on AML Data, RNA Surges on Study Data
As the third-quarter earnings season ends this week, the focus in the biotech sector is mostly on pipeline and key regulatory ...
Business Insider1d
Novavax price target lowered to $9 from $14 at TD Cowen
TD Cowen lowered the firm’s price target on Novavax (NVAX) to $9 from $14 and keeps a Hold rating on the shares. The firm said the FDA lifted its clinical hold on its COVID/flu combo and standalone ...
WPTV-TV2d
With holidays coming up, now is a good time to get flu and COVID-19 vaccines
Yes, you can get your flu and COVID-19 shots at the same time. Don't call them boosters — they're not just another dose of ...
Novavax Gains Competitive Edge with FDA Clearance and Strategic Collaborations, Earning Buy Rating
H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on Novavax (NVAX – Research Report) today and set a price target of ...
Hosted on MSN16d
Some Americans need more than one COVID booster this season, CDC says. What to know
Cold and flu season is upon us, and with it comes a new round of COVID-19 booster shots. The new 2024-2025 shots were ... There is an exception for those choosing to receive a Novavax vaccine, ...
Miami Herald16d
Some Americans need more than one COVID booster this season, CDC says. What to know
and with it comes a new round of COVID-19 booster shots. Expecting an increase in COVID-19 cases ahead of the holidays, the Biden Administration relaunched the free at-home COVID-19 test kits the ...